1_most_popular_icon

Most bought and sold shares last week

Equities 3 minutes to read
Note: This is marketing material. This article is not investment advice, capital is at risk.

The most bought and sold stocks last week.

US tech stocks continued to dominate the trading activity last week but we also saw a big jump in interest in two UK stocks.

Nvidia, Micron and SpaceX were the most traded names last week, with Microsoft also making the top five, a picture very similar to the week before.

But soaring up the rankings was easyJet, which took off last week as the airline became the subject of a bidding war by two US private equity groups seeking to take the firm private. However, clients were decisively net sellers with a buy% of just 31% as they took the opportunity of the price spike to take profits as share hit their highest since February 2022. 

Also rising up the rankings was AstraZeneca, with clients buying into the weakness as the stock tumbled following news of a disappointing drug trial. AstraZeneca saw the biggest jump in trading activity last week relative the week before, with easyJet coming in second place. A hefty 86% of trades in AZN last week were buys.

Bearish bets were made on a couple of the most popular and most widely held Magnificent 7 names as clients turned net sellers of Meta Platforms and Apple, with just 37% and 28% buy ratios respectively. Another Mag7 name to see selling was Amazon, with clients at 35% net buys.

SK Hynix debuted on the Nasdaq on Friday, with the stock making the most popular list of top traded names. However, the shares tumbled 15% in Seoul on Monday. The SK Hynix price in Seoul corresponds to its US ADR of $122.7 after closing at $168 on Friday.

Texas-based semiconductor company Applied Optoelectronics and Cardiff-based IQE plc, which makes wafer products for manufacturing semiconductors, were among the most popular stocks in terms of buy percentages last week. IQE has jumped 680% in 2026. Clients and analysts retained a bullish bias on SpaceX as the stock closed the week below its IPO opening price.

Here’s a list of our top 20 most traded stocks of the last week with the percentage of buys.

Top Stocks (Most Traded)

Buy%

NVIDIA Corp.

58%

Micron Technology Inc.

61%

Space Exploration Technologies Corp. - SpaceX

73%

EasyJet Plc

31%

Microsoft Corp.

72%

Oracle Corp.

75%

Intel Corp.

48%

Meta Platforms Inc.

37%

SanDisk Corp

54%

Marvell Technology Inc.

57%

AstraZeneca PLC

86%

Nebius Group NV

65%

Broadcom Inc.

64%

Palantir Technologies Inc.

41%

Rolls-Royce Holdings PLC

56%

Alibaba Group Holding Ltd - ADR

42%

Amazon.com Inc.

35%

Netflix Inc.

60%

Apple Inc.

28%

Bloom Energy Corp.

50%

 

Most Popular - strongest buy % among our top 50 traded stocks of the last week.

Top Stocks (Most Popular)

Buy%

SK Hynix Inc – pre order

100%

Applied Optoelectronics Inc.

88%

IQE Plc

86%

AstraZeneca PLC

86%

Oracle Corp.

75%

Space Exploration Technologies Corp. - SpaceX

73%

Microsoft Corp.

72%

Diageo Plc

71%

SK Hynix Inc

71%

AST SpaceMobile Inc.

67%

 

 

Read our H1 review and look at the best performing ETFs and investment trusts so far in 2026.

 

 

Outrageous Predictions 2026

01 /

  • Executive Summary: Outrageous Predictions 2026

    Outrageous Predictions

    Executive Summary: Outrageous Predictions 2026

    Saxo Group

    Saxo Group

    Read Saxo's Outrageous Predictions for 2026, our latest batch of low probability, but high impact ev...
  • A Fortune 500 company names an AI model as CEO

    Outrageous Predictions

    A Fortune 500 company names an AI model as CEO

    Charu Chanana

    Chief Investment Strategist

    Can AI be trusted to take over in the boardroom? With the right algorithms and balanced human oversi...
  • Dollar dominance challenged by Beijing’s golden yuan

    Outrageous Predictions

    Dollar dominance challenged by Beijing’s golden yuan

    Charu Chanana

    Chief Investment Strategist

    Beijing does an end-run around the US dollar, setting up a framework for settling trade in a neutral...
  • Obesity drugs for everyone – even for pets

    Outrageous Predictions

    Obesity drugs for everyone – even for pets

    Jacob Falkencrone

    Global Head of Investment Strategy

    The availability of GLP-1 drugs in pill form makes them ubiquitous, shrinking waistlines, even for p...
  • Dumb AI triggers trillion-dollar clean-up

    Outrageous Predictions

    Dumb AI triggers trillion-dollar clean-up

    Jacob Falkencrone

    Global Head of Investment Strategy

    Agentic AI systems are deployed across all sectors, and after a solid start, mistakes trigger a tril...
  • Quantum leap Q-Day arrives early, crashing crypto and destabilizing world finance

    Outrageous Predictions

    Quantum leap Q-Day arrives early, crashing crypto and destabilizing world finance

    Neil Wilson

    Investor Content Strategist

    A quantum computer cracks today’s digital security, bringing enough chaos with it that Bitcoin crash...
  • SpaceX announces an IPO, supercharging extraterrestrial markets

    Outrageous Predictions

    SpaceX announces an IPO, supercharging extraterrestrial markets

    John J. Hardy

    Global Head of Macro Strategy

    Financial markets go into orbit, to the moon and beyond as SpaceX expands rocket launches by orders-...
  • Britain’s Great EU Backdoor Return

    Outrageous Predictions

    Britain’s Great EU Backdoor Return

    Neil Wilson

    Investor Content Strategist

    Faced with rolling fiscal, economic, trade and political crises the UK government sneaks back into t...
  • Taylor Swift-Kelce wedding spikes global growth

    Outrageous Predictions

    Taylor Swift-Kelce wedding spikes global growth

    John J. Hardy

    Global Head of Macro Strategy

    Next year’s most anticipated wedding inspires Gen Z to drop the doomscrolling and dial up the real w...
  • Despite concerns, U.S. 2026 mid-term elections proceed smoothly

    Outrageous Predictions

    Despite concerns, U.S. 2026 mid-term elections proceed smoothly

    John J. Hardy

    Global Head of Macro Strategy

    In spite of outstanding threats to the American democratic process, the US midterms come and go cord...

This content is marketing material. 

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Capital Market Ltd. (SCML) provides execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice or a recommendation.

SCML content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

SCML partners with companies that provide compensation for promotional activities conducted on its platform. Some partners also pay retrocessions contingent on clients investing in products from those partners. 

While SCML receives compensation from these partnerships, all educational and research content remains focused on providing information to clients.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. SCML does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992